Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
- PMID: 27475283
- DOI: 10.1016/j.clnu.2016.07.004
Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
Abstract
Background: Chlorella vulgaris (C. vulgaris) is reported to improve dyslipidemia and hypertension; however, its effect on inflammatory biomarkers and insulin resistance has not been noticed thus far. Non-alcoholic fatty liver disease (NAFLD) as a hepatic symptom of metabolic syndrome is strongly associated with insulin resistance and inflammation.
Aim of the study: In the current interventional trial, we aimed to study the effects of C. vulgaris supplementation on glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with NAFLD.
Methods: Seventy NAFLD patients confirmed by ultra-sonographic findings were randomly assigned into intervention group (four 300 mg tablets of C. vulgaris) or placebo group (four 300 mg tablets of placebos) for 8 weeks. Anthropometric measurements, liver enzymes, fasting serum glucose (FSG), insulin, high sensitive C-reactive protein (hs-CRP) and tumor necrosis factor-alpha (TNF-α) were assessed and homeostatic model assessment (HOMA) score for insulin resistance was estimated before and after the intervention.
Results: Anthropometric measurements decreased significantly in both group (p < 0.001). However, mean reduction in weight was significantly higher in C. vulgaris - treated group compared to placebo group. Serum concentrations of liver enzymes, FSG and hs-CRP also significantly decreased and serum insulin concentration and HOMA score increased significantly only in C. vulgaris-treated group (P < 0.001, P < 0.006 and P < 0.025, respectively). Mean change in serum glucose and TNF-α levels were significant between the groups even after adjusting for the serum insulin and baseline values of variables (P = 0.014, P = 0.005, P = 0.014, respectively); between-group differences were not significant for the other variables by the end of study.
Conclusion: To our finding, C. vulgaris supplementation could be considered as an adjunctive therapy to decrease weight and improve glycemic status and reducing hs-CRP as well as improving liver function in patients with NAFLD.
Irct number: 201202233320N7.
Keywords: Chlorella vulgaris; Inflammation; Insulin resistance; Non-alcoholic fatty liver disease.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Similar articles
-
Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.Food Funct. 2022 Nov 14;13(22):11568-11578. doi: 10.1039/d2fo01280d. Food Funct. 2022. PMID: 36263703 Clinical Trial.
-
The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S975-S982. doi: 10.1016/j.dsx.2017.07.025. Epub 2017 Jul 20. Diabetes Metab Syndr. 2017. PMID: 28751149 Review.
-
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
-
Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.Diabetes Obes Metab. 2017 Dec;19(12):1805-1809. doi: 10.1111/dom.12989. Epub 2017 Jul 10. Diabetes Obes Metab. 2017. PMID: 28452101 Clinical Trial.
-
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.Annu Rev Nutr. 2016 Jul 17;36:275-99. doi: 10.1146/annurev-nutr-071715-050718. Epub 2016 May 4. Annu Rev Nutr. 2016. PMID: 27146015 Review.
Cited by
-
Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.Mar Drugs. 2024 May 3;22(5):210. doi: 10.3390/md22050210. Mar Drugs. 2024. PMID: 38786601 Free PMC article. Review.
-
Nicotine exacerbates liver damage in a mice model of Ehrlich ascites carcinoma through shifting SOD/NF-κB/caspase-3 pathways: ameliorating role of Chlorella vulgaris.Naunyn Schmiedebergs Arch Pharmacol. 2024 May 9. doi: 10.1007/s00210-024-03120-9. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38722343
-
Bioactive Peptides Derived from Edible Insects: Effects on Human Health and Possible Applications in Dentistry.Nutrients. 2023 Oct 30;15(21):4611. doi: 10.3390/nu15214611. Nutrients. 2023. PMID: 37960264 Free PMC article. Review.
-
The utility of algae as sources of high value nutritional ingredients, particularly for alternative/complementary proteins to improve human health.Front Nutr. 2023 Oct 13;10:1277343. doi: 10.3389/fnut.2023.1277343. eCollection 2023. Front Nutr. 2023. PMID: 37904788 Free PMC article. Review.
-
Nutrient synergy: definition, evidence, and future directions.Front Nutr. 2023 Oct 12;10:1279925. doi: 10.3389/fnut.2023.1279925. eCollection 2023. Front Nutr. 2023. PMID: 37899823 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous